Candel Therapeutics

Candel Therapeutics CADL Stock

$5.32   -1.481480%
Add to favorites
Market Cap
$417.33M
LOW - HIGH [24H]
$5.26 - $5.64
VOLUME [24H]
$1.36M
P/E Ratio
0
Earnings per share
-$1.53
ISIN
US1374041093
Price   Prediction

Candel Therapeutics Price Chart

Sorry, that's all we've gotfor now...

Candel Therapeutics (CADL) stock price today is 5.32 USD on Tech Market Middle (-1.48% on the day). Updated .

Candel Therapeutics CADL Financial and Trading Overview

Candel Therapeutics stock price 5.32 USD
Previous Close 5.4 USD
Open 5.35 USD
Bid 7.49 USD x 200
Ask 13.51 USD x 200
Day's Range 5.26 - 5.64 USD
52 Week Range 4.35 - 14 USD
Volume 464.13K USD
Avg. Volume 1.28M USD
Market Cap 424.39M USD
Beta (5Y Monthly) -0.287
PE Ratio (TTM) N/A
EPS (TTM) -1.53 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 17.67 USD

CADL Valuation Measures

Enterprise Value 270.26M USD
Trailing P/E N/A
Forward P/E -3.7700348
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 3.2259986
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.332

Trading Information

Candel Therapeutics Stock Price History

Beta (5Y Monthly) -0.287
52-Week Change 22.17%
S&P500 52-Week Change 10.51%
52 Week High 14 USD
52 Week Low 4.35 USD
50-Day Moving Average 9.47 USD
200-Day Moving Average 8.4 USD

CADL Share Statistics

Avg. Volume (3 month) 1.28M USD
Avg. Daily Volume (10-Days) 1.99M USD
Shares Outstanding 78.45M
Float 62.15M
Short Ratio 13.53
% Held by Insiders 14.28%
% Held by Institutions 64.56%
Shares Short 13.09M
Short % of Float 21.30%
Short % of Shares Outstanding 16.67%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -33.53%
Return on Equity (ttm) -93.64%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -81102000 USD
Net Income Avi to Common (ttm) -99135000 USD
Diluted EPS (ttm) -1.53
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 203.12M USD
Total Cash Per Share (mrq) 2.59 USD
Total Debt (mrq) 49.77M USD
Total Debt/Equity (mrq) 37.82 USD
Current Ratio (mrq) 7.571
Book Value Per Share (mrq) 1.677

Cash Flow Statement

Operating Cash Flow (ttm) -68906000 USD
Levered Free Cash Flow (ttm) -26526750 USD

Profile of Candel Therapeutics

Country United States
State MA
City Needham
Address 117 Kendrick Street
ZIP 02494
Phone 617 916 5445
Website https://www.candeltx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 55

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients. It develops CAN-2409, which is in Phase 2a clinical trials for the treatment of prostate cancer; and Phase 2a clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent high-grade glioma. In addition, it develops the enLIGHTEN Discovery Platform, a systematic, iterative herpes simplex virus based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapy candidates for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.

Q&A For Candel Therapeutics Stock

What is a current CADL stock price?

Candel Therapeutics CADL stock price today per share is 5.32 USD.

How to purchase Candel Therapeutics stock?

You can buy CADL shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Candel Therapeutics?

The stock symbol or ticker of Candel Therapeutics is CADL.

Which industry does the Candel Therapeutics company belong to?

The Candel Therapeutics industry is Biotechnology.

How many shares does Candel Therapeutics have in circulation?

The max supply of Candel Therapeutics shares is 78.45M.

What is Candel Therapeutics Price to Earnings Ratio (PE Ratio)?

Candel Therapeutics PE Ratio is now.

What was Candel Therapeutics earnings per share over the trailing 12 months (TTM)?

Candel Therapeutics EPS is -1.53 USD over the trailing 12 months.

Which sector does the Candel Therapeutics company belong to?

The Candel Therapeutics sector is Healthcare.

Candel Therapeutics CADL included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24429.89 USD —
+0.42
6.97B USD — 24225.3 USD — 24538.78 USD — — 6.97B USD —
us US Tech Health Care IXHC US 1324.44 USD —
-0.63
— — 1322.85 USD — 1342.46 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
us US Tech Global Market Composite NQGM US 1839.01 USD —
+0.18
— — 1830.2 USD — 1855.92 USD — — — —
us US Tech Biotechnology NBI US 6971.7 USD —
-0.66
— — 6959.96 USD — 7076.43 USD — — — —
$2.16T
Total marketcap
$70.95B
Total volume
BTC 57.99%   •   ETH 9.89%
Dominance
Select currency